Arrowstreet Capital’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,025,693
| Closed | -$22.6M | – | 1835 |
|
2024
Q4 | $22.6M | Sell |
1,025,693
-278,297
| -21% | -$6.13M | 0.02% | 566 |
|
2024
Q3 | $22M | Buy |
1,303,990
+637,802
| +96% | +$10.7M | 0.02% | 520 |
|
2024
Q2 | $7.96M | Sell |
666,188
-879,624
| -57% | -$10.5M | 0.01% | 709 |
|
2024
Q1 | $17.1M | Buy |
1,545,812
+235,216
| +18% | +$2.61M | 0.02% | 537 |
|
2023
Q4 | $11.4M | Buy |
1,310,596
+427,507
| +48% | +$3.7M | 0.01% | 534 |
|
2023
Q3 | $6.76M | Buy |
+883,089
| New | +$6.76M | 0.01% | 608 |
|
2022
Q2 | – | Sell |
-19,811
| Closed | -$127K | – | 1254 |
|
2022
Q1 | $127K | Buy |
+19,811
| New | +$127K | ﹤0.01% | 1131 |
|